Trump claims new drug brings dead people back to life

At a recent press event, Donald Trump made a claim that a new drug has been used on patients who were “dead” and brought them back.

“We’ve taken people that were dead. We had a person given the last rites — gone, the kids are crying and everything — and started them on this drug. And the person became better. It works,” he said.

The statement has been spreading fast. But the context behind it tells a very different story.

Trump wasn’t announcing a new medical breakthrough. He was talking about the Right to Try Act, a policy passed during his first administration. The law allows terminally ill patients to access experimental treatments that haven’t been fully approved yet.

These treatments are high-risk, often unproven, and used as last-resort options. Sometimes, patients do improve after trying these treatments.

But that is very different from what Trump described.

Where the “bringing people back” claim comes from

In this instance, the claim appears to be an exaggeration. Doctors occasionally see cases where patients who are extremely ill (even near death) respond unexpectedly to treatment.

That can look as dramatic as recovery happening against expectations, with patients stabilizing suddenly and symptoms improving. But medically, that is not the same as someone being dead and returning to life.

Claims involving reversing death, miracle recoveries, and unnamed drugs with extreme effects typically require clinical evidence, peer-reviewed data, and clear scientific validation. None of that was presented here, and no specific drug was identified in the statement.

The debate around “Right to Try”

The Right to Try Act itself has been controversial. Supporters argue it gives patients more freedom to try potentially life-saving treatments. Critics say patients already had similar access before the law, and that it may expose vulnerable people to unproven therapies and reduce legal protections if treatments go wrong.

So even without exaggerated claims, the policy itself is still debated.

Source: Futurism